Borrelia burgdorferi VlsE1 - IgG

What It Means If the Marker "Borrelia burgdorferi VlsE1 - IgG" is Elevated on a Tick-Borne Panel by Vibrant Wellness

The Borrelia burgdorferi VlsE1 - IgG marker is critical for diagnosing Lyme disease, a condition caused by the Borrelia burgdorferi bacteria transmitted through ticks. Elevated levels of this marker on a Tick-Borne panel by Vibrant Wellness may indicate either past or current infection with Lyme disease. Understanding what this result means in the context of Lyme disease diagnosis and interpreting the test results can be vital in managing your health.

Understanding Borrelia burgdorferi and the Role of VlsE1

Borrelia burgdorferi is a bacterium responsible for Lyme disease, commonly transmitted by the bite of an infected Ixodes tick. Once infected, the body produces antibodies against the bacteria, including IgG antibodies. The VlsE1 protein is one of the key antigens produced by the bacteria and is particularly useful for diagnosing Lyme disease, as it is the most sensitive marker for IgG antibody detection in all stages of the disease.

CDC and Alternative Criteria for Interpreting Lyme Disease Test Results

When interpreting Lyme disease test results, including Borrelia burgdorferi VlsE1 - IgG, medical professionals refer to specific criteria to determine if Lyme disease is present. There are two main sets of criteria used: CDC Criteria and Alternative Criteria.

IgM Criteria for Lyme Disease

• CDC Criteria: One positive result for VlsE1, C6 peptide, or WCS, along with two of the following three antigens being positive — 23-25, 39, or 41.

• Alternative Criteria: One positive or borderline result for VlsE1, C6 peptide, or WCS, along with two of the following six antigens being positive or borderline — 23-25, 31, 34, 39, 41, or 83-93.

IgG Criteria for Lyme Disease

• CDC Criteria: One positive result for VlsE1, C6 peptide, or WCS, along with five of the following ten antigens being positive — 18, 23-25, 28, 30, 39, 41, 45, 58, 66, or 83-93.

• Alternative Criteria: One positive or borderline result for VlsE1, C6 peptide, or WCS, along with two of the following twelve antigens being positive or borderline — 18, 23-25, 28, 30, 31, 34, 39, 41, 45, 58, 66, or 83-93.

These criteria are used to help healthcare providers make an accurate diagnosis based on the patterns of antibodies detected in the blood.

What an Elevated Borrelia burgdorferi VlsE1 - IgG Marker Means

An elevated Borrelia burgdorferi VlsE1 - IgG marker suggests one of the following:

1. Previous or Recent Lyme Disease Exposure: Elevated IgG levels often indicate that you’ve had Lyme disease in the past and your immune system has responded by producing antibodies.

2. Chronic or Persistent Lyme Disease: Chronic Lyme disease can occur when the infection is not fully treated, leading to persistent symptoms that can include joint pain, neurological issues, and fatigue. Elevated IgG levels can indicate this prolonged infection.

3. False Positive or Cross-Reactivity: Though elevated IgG levels are a strong indicator of Lyme disease, cross-reactivity from other infections or autoimmune disorders may lead to false positives. Therefore, it’s essential to interpret results alongside symptoms and other diagnostic tests.

Symptoms of Lyme Disease

If your Borrelia burgdorferi VlsE1 - IgG result is elevated, it may be important to consider the following symptoms commonly associated with Lyme disease:

• Fatigue and muscle aches

• Joint pain or swelling

• Headaches

• Cognitive difficulties (brain fog, memory loss)

• Characteristic bull's-eye rash (erythema migrans)

• Neurological symptoms (nerve pain, facial palsy)

Treatment and Next Steps

If you have an elevated Borrelia burgdorferi VlsE1 - IgG marker, further steps should include:

1. Clinical Evaluation: Consult with a healthcare provider to assess your symptoms, exposure risk, and potential Lyme disease progression.

2. Additional Testing: A more thorough evaluation with follow-up testing, such as PCR or Western blot, may be recommended to confirm the diagnosis.

3. Appropriate Treatment: If Lyme disease is confirmed, treatment typically involves antibiotics to eliminate the bacteria. Chronic cases may require more tailored treatment approaches.

Conclusion

An elevated Borrelia burgdorferi VlsE1 - IgG marker on a Tick-Borne panel by Vibrant Wellness is a significant indicator of Lyme disease exposure, either from a past infection or ongoing chronic disease. It is essential to interpret these results carefully with the help of a healthcare professional, especially in the context of any symptoms you may be experiencing. Lyme disease is a complex illness, but with the right diagnosis and treatment, individuals can manage and recover effectively.

Borreliella burgdorferi is one of the pathogens of the Borreliella burgdorferi sensu lato complex causing Lyme disease. Lyme disease is a zoonotic, vector-borne disease transmitted by the Ixodes tick. Clinical presentation of Lyme disease is known for the characteristic bull's-eye rash (also known as erythema migrans) but can also include myocarditis, cardiomyopathy, arrythmia, arthritis, arthralgia, meningitis, neuropathies, and facial nerve palsy depending on the stage of infection.